| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8431098 | Biology of Blood and Marrow Transplantation | 2016 | 8 Pages |
Abstract
- One third of HLA-identical sibling donor transplant recipients never ever develop any graft-versus-host disease
- This rate of no graft-versus-host disease is significantly higher with male donors in female recipients
- Factors associated with no graft-versus-host disease should become a target of precision medicine
- Prediction of no graft-versus-host disease could become a decision-guiding tool for early transplantations
- Such an approach could spare immunosuppression, improve survival, and reduce costs
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Alois Gratwohl, Carmen Ruiz de Elvira, Michael Gratwohl, Hildegard T. Greinix, Rafael Duarte,